Global (United States, European Union and China) Opioids Drug Market Research Report 2019-2025

1 Study Coverage

• 1.1 Opioids Drug Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Opioids Drug Market Size Growth Rate by Type
  • 1.2.2 Oxycodone
  • 1.2.3 Hydromorphone
  • 1.2.4 Codeine
  • 1.2.5 Fentanyl
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Opioids Drug Market Size Growth Rate by Application
  • 1.3.2 Pain Relief
  • 1.3.3 Anesthesia
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Opioids Drug Market Size Estimates and Forecasts
  • 2.1.1 Global Opioids Drug Revenue 2015-2026
  • 2.1.2 Global Opioids Drug Sales 2015-2026
• 2.2 Opioids Drug Market Size by Region: 2020 Versus 2026
• 2.3 Opioids Drug Sales by Region (2015-2026)
  • 2.3.1 Global Opioids Drug Sales by Region: 2015-2020
  • 2.3.2 Global Opioids Drug Sales Forecast by Region (2021-2026)
  • 2.3.3 Global Opioids Drug Sales Market Share by Region (2015-2026)
• 2.4 Opioids Drug Market Estimates and Projections by Region (2021-2026)
  • 2.4.1 Global Opioids Drug Revenue by Region: 2015-2020
  • 2.4.2 Global Opioids Drug Revenue Forecast by Region (2021-2026)
  • 2.4.3 Global Opioids Drug Revenue Market Share by Region (2015-2026)

3 Global Opioids Drug by Manufacturers

• 3.1 Global Top Opioids Drug Manufacturers by Sales
  • 3.1.1 Global Opioids Drug Sales by Manufacturer (2015-2020)
  • 3.1.2 Global Opioids Drug Sales Market Share by Manufacturer (2015-2019)
• 3.2 Global Top Opioids Drug Manufacturers by Revenue
  • 3.2.1 Global Opioids Drug Revenue by Manufacturer (2015-2020)
  • 3.2.2 Global Opioids Drug Revenue Share by Manufacturer (2015-2020)
• 3.3 Global Opioids Drug Price by Manufacturer (2015-2020)
• 3.4 Competitive Landscape
  • 3.4.1 Key Opioids Drug Manufacturers Covered: Ranking by Revenue
  • 3.4.2 Global Opioids Drug Market Concentration Ratio (CR5 and HHI) & (2015-2020)
  • 3.4.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.5 Global Opioids Drug Manufacturing Base Distribution, Product Type
  • 3.5.1 Opioids Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.5.2 Manufacturers Opioids Drug Product Type
  • 3.5.3 Date of International Manufacturers Enter into Opioids Drug Market
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

• 4.1 Teva
  • 4.1.1 Teva Corporation Information
  • 4.1.2 Teva Description, Business Overview
  • 4.1.3 Teva Opioids Drug Products Offered
  • 4.1.4 Teva Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.1.5 Teva Opioids Drug Revenue by Product
  • 4.1.6 Teva Opioids Drug Revenue by Application
  • 4.1.7 Teva Opioids Drug Revenue by Geographic Area
  • 4.1.8 Teva Opioids Drug Revenue by Sales Channel
  • 4.1.9 Teva Recent Development
• 4.2 Purdue Pharma
  • 4.2.1 Purdue Pharma Corporation Information
  • 4.2.2 Purdue Pharma Description, Business Overview
  • 4.2.3 Purdue Pharma Opioids Drug Products Offered
  • 4.2.4 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.2.5 Purdue Pharma Opioids Drug Revenue by Product
  • 4.2.6 Purdue Pharma Opioids Drug Revenue by Application
  • 4.2.7 Purdue Pharma Opioids Drug Revenue by Geographic Area
  • 4.2.8 Purdue Pharma Opioids Drug Revenue by Sales Channel
  • 4.2.9 Purdue Pharma Recent Development
• 4.3 Mallinckrodt
  • 4.3.1 Mallinckrodt Corporation Information
  • 4.3.2 Mallinckrodt Description, Business Overview
  • 4.3.3 Mallinckrodt Opioids Drug Products Offered
  • 4.3.4 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.3.5 Mallinckrodt Opioids Drug Revenue by Product
  • 4.3.6 Mallinckrodt Opioids Drug Revenue by Application
  • 4.3.7 Mallinckrodt Opioids Drug Revenue by Geographic Area
  • 4.3.8 Mallinckrodt Opioids Drug Revenue by Sales Channel
  • 4.3.9 Mallinckrodt Recent Development
• 4.4 Amneal Pharma
  • 4.4.1 Amneal Pharma Corporation Information
  • 4.4.2 Amneal Pharma Description, Business Overview
  • 4.4.3 Amneal Pharma Opioids Drug Products Offered
  • 4.4.4 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.4.5 Amneal Pharma Opioids Drug Revenue by Product
  • 4.4.6 Amneal Pharma Opioids Drug Revenue by Application
  • 4.4.7 Amneal Pharma Opioids Drug Revenue by Geographic Area
  • 4.4.8 Amneal Pharma Opioids Drug Revenue by Sales Channel
  • 4.4.9 Amneal Pharma Recent Development
• 4.5 Collegium
  • 4.5.1 Collegium Corporation Information
  • 4.5.2 Collegium Description, Business Overview
  • 4.5.3 Collegium Opioids Drug Products Offered
  • 4.5.4 Collegium Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.5.5 Collegium Opioids Drug Revenue by Product
  • 4.5.6 Collegium Opioids Drug Revenue by Application
  • 4.5.7 Collegium Opioids Drug Revenue by Geographic Area
  • 4.5.8 Collegium Opioids Drug Revenue by Sales Channel
  • 4.5.9 Collegium Recent Development
• 4.6 J&J
  • 4.6.1 J&J Corporation Information
  • 4.6.2 J&J Description, Business Overview
  • 4.6.3 J&J Opioids Drug Products Offered
  • 4.6.4 J&J Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.6.5 J&J Opioids Drug Revenue by Product
  • 4.6.6 J&J Opioids Drug Revenue by Application
  • 4.6.7 J&J Opioids Drug Revenue by Geographic Area
  • 4.6.8 J&J Recent Development
• 4.7 Endo
  • 4.7.1 Endo Corporation Information
  • 4.7.2 Endo Description, Business Overview
  • 4.7.3 Endo Opioids Drug Products Offered
  • 4.7.4 Endo Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.7.5 Endo Opioids Drug Revenue by Product
  • 4.7.6 Endo Opioids Drug Revenue by Application
  • 4.7.7 Endo Opioids Drug Revenue by Geographic Area
  • 4.7.8 Endo Recent Development
• 4.8 Pfizer
  • 4.8.1 Pfizer Corporation Information
  • 4.8.2 Pfizer Description, Business Overview
  • 4.8.3 Pfizer Opioids Drug Products Offered
  • 4.8.4 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.8.5 Pfizer Opioids Drug Revenue by Product
  • 4.8.6 Pfizer Opioids Drug Revenue by Application
  • 4.8.7 Pfizer Opioids Drug Revenue by Geographic Area
  • 4.8.8 Pfizer Recent Development
• 4.9 INSYS
  • 4.9.1 INSYS Corporation Information
  • 4.9.2 INSYS Description, Business Overview
  • 4.9.3 INSYS Opioids Drug Products Offered
  • 4.9.4 INSYS Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.9.5 INSYS Opioids Drug Revenue by Product
  • 4.9.6 INSYS Opioids Drug Revenue by Application
  • 4.9.7 INSYS Opioids Drug Revenue by Geographic Area
  • 4.9.8 INSYS Recent Development
• 4.10 Mylan
  • 4.10.1 Mylan Corporation Information
  • 4.10.2 Mylan Description, Business Overview
  • 4.10.3 Mylan Opioids Drug Products Offered
  • 4.10.4 Mylan Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.10.5 Mylan Opioids Drug Revenue by Product
  • 4.10.6 Mylan Opioids Drug Revenue by Application
  • 4.10.7 Mylan Opioids Drug Revenue by Geographic Area
  • 4.10.8 Mylan Recent Development
• 4.11 Hikma
  • 4.11.1 Hikma Corporation Information
  • 4.11.2 Hikma Description, Business Overview
  • 4.11.3 Hikma Opioids Drug Products Offered
  • 4.11.4 Hikma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.11.5 Hikma Opioids Drug Revenue by Product
  • 4.11.6 Hikma Opioids Drug Revenue by Application
  • 4.11.7 Hikma Opioids Drug Revenue by Geographic Area
  • 4.11.8 Hikma Recent Development
• 4.12 Egalet
  • 4.12.1 Egalet Corporation Information
  • 4.12.2 Egalet Description, Business Overview
  • 4.12.3 Egalet Opioids Drug Products Offered
  • 4.12.4 Egalet Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
  • 4.12.5 Egalet Opioids Drug Revenue by Product
  • 4.12.6 Egalet Opioids Drug Revenue by Application
  • 4.12.7 Egalet Opioids Drug Revenue by Geographic Area
  • 4.12.8 Egalet Recent Development

5 Breakdown Data by Type

• 5.1 Global Opioids Drug Sales by Type (2015-2026)
  • 5.1.1 Global Opioids Drug Sales by Type (2015-2020)
  • 5.1.2 Global Opioids Drug Sales Forecast by Type (2021-2026)
  • 5.1.3 Global Opioids Drug Sales Market Share by Type (2015-2026)
• 5.2 Global Opioids Drug Revenue Forecast by Type (2015-2026)
  • 5.2.1 Global Opioids Drug Revenue by Type (2015-2020)
  • 5.2.2 Global Opioids Drug Revenue Forecast by Type (2021-2026)
  • 5.2.3 Global Opioids Drug Revenue Market Share by Type (2015-2026)
• 5.3 Opioids Drug Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

• 6.1 Global Opioids Drug Sales by Application (2015-2026)
  • 6.1.1 Global Opioids Drug Sales by Application (2015-2020)
  • 6.1.2 Global Opioids Drug Sales Forecast by Application (2021-2026)
  • 6.1.3 Global Opioids Drug Sales Market Share by Application (2015-2026)
• 6.2 Global Opioids Drug Revenue Forecast by Application (2015-2026)
  • 6.2.1 Global Opioids Drug Revenue by Application (2015-2020)
  • 6.2.2 Global Opioids Drug Revenue Forecast by Application (2021-2026)
  • 6.2.3 Global Opioids Drug Revenue Market Share by Application (2015-2026)
• 6.3 Opioids Drug Average Selling Price (ASP) by Application (2015-2026)

7 North America

• 7.1 North America Opioids Drug Market Size YoY Growth 2015-2026
• 7.2 North America Opioids Drug Market Facts & Figures by Country
  • 7.2.1 North America Opioids Drug Sales by Country (2015-2026)
  • 7.2.2 North America Opioids Drug Revenue by Country (2015-2026)
• 7.3 North America Opioids Drug Sales by Type
• 7.4 North America Opioids Drug Sales by Application

8 Asia-Pacific

• 8.1 Asia-Pacific Opioids Drug Market Size YoY Growth 2015-2026
• 8.2 Asia-Pacific Opioids Drug Market Facts & Figures by Region
  • 8.2.1 Asia-Pacific Opioids Drug Sales by Region (2015-2026)
  • 8.2.2 Asia-Pacific Opioids Drug Revenue by Region (2015-2026)
• 8.3 Asia-Pacific Opioids Drug Sales by Type
• 8.4 Asia-Pacific Opioids Drug Sales by Application

9 Europe

• 9.1 Europe Opioids Drug Market Size YoY Growth 2015-2026
• 9.2 Europe Opioids Drug Market Facts & Figures by Country
  • 9.2.1 Europe Opioids Drug Sales by Country (2015-2026)
  • 9.2.2 Europe Opioids Drug Revenue by Country (2015-2026)
• 9.3 Europe Opioids Drug Sales by Type
• 9.4 Europe Opioids Drug Sales by Application

10 Latin America

• 10.1 Latin America Opioids Drug Market Size YoY Growth 2015-2026
• 10.2 Latin America Opioids Drug Market Facts & Figures by Country
  • 10.2.1 Latin America Opioids Drug Sales by Country (2015-2026)
  • 10.2.2 Latin America Opioids Drug Revenue by Country (2015-2026)
• 10.3 Latin America Opioids Drug Sales by Type
• 10.4 Latin America Opioids Drug Sales by Application

11 Middle East and Africa

• 11.1 Middle East and Africa Opioids Drug Market Size YoY Growth 2015-2026
• 11.2 Middle East and Africa Opioids Drug Market Facts & Figures by Country
  • 11.2.1 Middle East and Africa Opioids Drug Sales by Country (2015-2026)
  • 11.2.2 Middle East and Africa Opioids Drug Revenue by Country (2015-2026)
• 11.3 Middle East and Africa Opioids Drug Sales by Type
• 11.4 Middle East and Africa Opioids Drug Sales by Application

12 Supply Chain and Sales Channel Analysis

• 12.1 Opioids Drug Supply Chain Analysis
• 12.2 Opioids Drug Key Raw Materials and Upstream Suppliers
• 12.3 Opioids Drug Clients Analysis
• 12.4 Opioids Drug Sales Channel and Sales Model Analysis
  • 12.4.1 Opioids Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 12.4.2 Opioids Drug Distribution Channel Analysis: Online Sales VS Offline Sales
  • 12.4.3 Opioids Drug Distributors

13 Market Dynamics

• 13.1 Opioids Drug Market Drivers
• 13.2 Opioids Drug Market Opportunities
• 13.3 Opioids Drug Market Challenges
• 13.4 Opioids Drug Market Restraints
• 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details